Drug firm Suven Life Sciences Ltd today reported over four-fold increase in its standalone net profit at Rs 36.43 crore for the quarter ended December 2013, on account of higher sales.
The company had posted a standalone net profit of Rs 7.75 crore in the same period of previous fiscal, Suven Life Sciences said in a filing with the BSE.
Its net sales during the quarter under review were at Rs 119.42 crore as against Rs 62.39 crore in the year-ago period.
The overall expenses were at Rs 66.79 crore in the October-December quarter as compared to Rs 49.71 crore during the same period of 2012.
The company's stock closed at Rs 78.10 per scrip, down 0.89 per cent, on the BSE.
